Factors Significantly Associated With Survival in Multivariate Analysis of 113 Recipients of HLA-Identical Sibling Bone Marrow Transplants for Low-Grade Non-Hodgkin’s Lymphoma Reported to the IBMTR by 50 Centers Worldwide
| Covariate . | No. . | RR of Death . | 95% CI . | P Value* . |
|---|---|---|---|---|
| KPS pretransplant | ||||
| <90% | 33 | 1.00 | — | |
| ≥90% | 80 | 0.42 | (0.23-0.77) | .005 |
| Conditioning regimen | ||||
| Chemotherapy alone | 20 | 1.00 | — | |
| TBI + chemotherapy | 93 | 0.47 | (0.24-0.93) | .03 |
| Sensitivity to chemotherapy | ||||
| Resistant | 66 | 1.00 | — | |
| Sensitive | 39 | 0.50 | (0.27-0.91) | .02* |
| Unknown | 8 | 1.02 | (0.35-2.99) | .97* |
| Age at transplant (yr) | ||||
| <40 | 63 | 1.00 | — | |
| ≥40 | 50 | 1.85 | (1.05-3.24) | .03* |
| Covariate . | No. . | RR of Death . | 95% CI . | P Value* . |
|---|---|---|---|---|
| KPS pretransplant | ||||
| <90% | 33 | 1.00 | — | |
| ≥90% | 80 | 0.42 | (0.23-0.77) | .005 |
| Conditioning regimen | ||||
| Chemotherapy alone | 20 | 1.00 | — | |
| TBI + chemotherapy | 93 | 0.47 | (0.24-0.93) | .03 |
| Sensitivity to chemotherapy | ||||
| Resistant | 66 | 1.00 | — | |
| Sensitive | 39 | 0.50 | (0.27-0.91) | .02* |
| Unknown | 8 | 1.02 | (0.35-2.99) | .97* |
| Age at transplant (yr) | ||||
| <40 | 63 | 1.00 | — | |
| ≥40 | 50 | 1.85 | (1.05-3.24) | .03* |
Abbreviation: RR, relative risk.
P value for pairwise comparison of specific category with the reference (baseline) group.